APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Normal Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Normal Immunoglobulin Industry Growth and Trends Forecast to 2032

19 December 2025104 pages

Choose your research edition.

Industry ResearchHuman Normal Immunoglobulin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Normal Immunoglobulin Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Normal Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Normal Immunoglobulin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Normal Immunoglobulin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Normal Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Normal Immunoglobulin include ADMA Biologics, Biotest, CBPO, CNBG, CSL Behring, Emergent (Cangene), Grifols, Kamada and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Normal Immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Normal Immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Normal Immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Normal Immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Normal Immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Normal Immunoglobulin Market by Company

ADMA Biologics

Biotest

CBPO

CNBG

CSL Behring

Emergent (Cangene)

Grifols

Kamada

Kedrion

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

Human Normal Immunoglobulin Segment by Type

Hepatitis B Immunoglobulins

Tetanus Immunoglobulins

Rabies Immunoglobulins

Others

Human Normal Immunoglobulin Segment by Application

Government Institutions

Private Sector

Other

Human Normal Immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Normal Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Normal Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Normal Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Normal Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Normal Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis B Immunoglobulins Table 2. Major Company of Tetanus Immunoglobulins Table 3. Major Company of Rabies Immunoglobulins Table 4. Major Company of Others Table 5. Global Human Normal Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 7. Global Human Normal Immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Human Normal Immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 10. Global Human Normal Immunoglobulin Price by Type (2021-2026) & (US$/Unit) Table 11. Global Human Normal Immunoglobulin Sales by Type (2027-2032) & (K Units) Table 12. Global Human Normal Immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Human Normal Immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Human Normal Immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 15. Global Human Normal Immunoglobulin Price by Type (2027-2032) & (US$/Unit) Table 16. North America Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 17. North America Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 19. Europe Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 23. Latin America Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Human Normal Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 26. Human Normal Immunoglobulin Industry Trends Table 27. Human Normal Immunoglobulin Industry Drivers Table 28. Human Normal Immunoglobulin Industry Opportunities and Challenges Table 29. Human Normal Immunoglobulin Industry Restraints Table 30. Global Human Normal Immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Human Normal Immunoglobulin Revenue Market Share by Company (2021-2026) Table 32. Global Human Normal Immunoglobulin Sales by Company (2021-2026) & (K Units) Table 33. Global Human Normal Immunoglobulin Sales Share by Company (2021-2026) Table 34. Global Human Normal Immunoglobulin Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Human Normal Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Human Normal Immunoglobulin Major Company Production Sites and Headquarters Table 37. Global Human Normal Immunoglobulin Company, Product Type & Application Table 38. Global Human Normal Immunoglobulin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Human Normal Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Human Normal Immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Human Normal Immunoglobulin Sales by Region (2021-2026) & (K Units) Table 43. Global Human Normal Immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Human Normal Immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Human Normal Immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 46. Global Human Normal Immunoglobulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Human Normal Immunoglobulin Sales by Region (2027-2032) & (K Units) Table 48. Global Human Normal Immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Human Normal Immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Human Normal Immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 51. Global Human Normal Immunoglobulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Human Normal Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 54. Global Human Normal Immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Human Normal Immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 57. Global Human Normal Immunoglobulin Price by Application (2021-2026) & (US$/Unit) Table 58. Global Human Normal Immunoglobulin Sales by Application (2027-2032) & (K Units) Table 59. Global Human Normal Immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Human Normal Immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Human Normal Immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 62. Global Human Normal Immunoglobulin Price by Application (2027-2032) & (US$/Unit) Table 63. North America Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 64. North America Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 66. Europe Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 70. Latin America Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Human Normal Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 73. ADMA Biologics Company Information Table 74. ADMA Biologics Business Overview Table 75. ADMA Biologics Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. ADMA Biologics Human Normal Immunoglobulin Product Portfolio Table 77. ADMA Biologics Recent Development Table 78. Biotest Company Information Table 79. Biotest Business Overview Table 80. Biotest Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Biotest Human Normal Immunoglobulin Product Portfolio Table 82. Biotest Recent Development Table 83. CBPO Company Information Table 84. CBPO Business Overview Table 85. CBPO Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. CBPO Human Normal Immunoglobulin Product Portfolio Table 87. CBPO Recent Development Table 88. CNBG Company Information Table 89. CNBG Business Overview Table 90. CNBG Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CNBG Human Normal Immunoglobulin Product Portfolio Table 92. CNBG Recent Development Table 93. CSL Behring Company Information Table 94. CSL Behring Business Overview Table 95. CSL Behring Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. CSL Behring Human Normal Immunoglobulin Product Portfolio Table 97. CSL Behring Recent Development Table 98. Emergent (Cangene) Company Information Table 99. Emergent (Cangene) Business Overview Table 100. Emergent (Cangene) Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Emergent (Cangene) Human Normal Immunoglobulin Product Portfolio Table 102. Emergent (Cangene) Recent Development Table 103. Grifols Company Information Table 104. Grifols Business Overview Table 105. Grifols Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Grifols Human Normal Immunoglobulin Product Portfolio Table 107. Grifols Recent Development Table 108. Kamada Company Information Table 109. Kamada Business Overview Table 110. Kamada Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Kamada Human Normal Immunoglobulin Product Portfolio Table 112. Kamada Recent Development Table 113. Kedrion Company Information Table 114. Kedrion Business Overview Table 115. Kedrion Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Kedrion Human Normal Immunoglobulin Product Portfolio Table 117. Kedrion Recent Development Table 118. Hualan Bio Company Information Table 119. Hualan Bio Business Overview Table 120. Hualan Bio Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hualan Bio Human Normal Immunoglobulin Product Portfolio Table 122. Hualan Bio Recent Development Table 123. Shanghai RAAS Company Information Table 124. Shanghai RAAS Business Overview Table 125. Shanghai RAAS Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Shanghai RAAS Human Normal Immunoglobulin Product Portfolio Table 127. Shanghai RAAS Recent Development Table 128. Sichuan Yuanda Shuyang Company Information Table 129. Sichuan Yuanda Shuyang Business Overview Table 130. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Portfolio Table 132. Sichuan Yuanda Shuyang Recent Development Table 133. North America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 135. North America Human Normal Immunoglobulin Sales Market Share by Country (2021-2026) Table 136. North America Human Normal Immunoglobulin Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Human Normal Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 138. North America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Human Normal Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Human Normal Immunoglobulin Market Share by Country (2021-2026) Table 141. North America Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Human Normal Immunoglobulin Market Share Forecast by Country (2027-2032) Table 143. Europe Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 145. Europe Human Normal Immunoglobulin Sales Market Share by Country (2021-2026) Table 146. Europe Human Normal Immunoglobulin Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Human Normal Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Human Normal Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Human Normal Immunoglobulin Market Share by Country (2021-2026) Table 151. Europe Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Human Normal Immunoglobulin Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Human Normal Immunoglobulin Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Human Normal Immunoglobulin Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Human Normal Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Human Normal Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Human Normal Immunoglobulin Market Share by Country (2021-2026) Table 161. Asia-Pacific Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Human Normal Immunoglobulin Market Share Forecast by Country (2027-2032) Table 163. Latin America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 165. Latin America Human Normal Immunoglobulin Sales Market Share by Country (2021-2026) Table 166. Latin America Human Normal Immunoglobulin Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Human Normal Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Human Normal Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Human Normal Immunoglobulin Market Share by Country (2021-2026) Table 171. Latin America Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Human Normal Immunoglobulin Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Human Normal Immunoglobulin Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Human Normal Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Human Normal Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Human Normal Immunoglobulin Market Share by Country (2021-2026) Table 181. Middle East and Africa Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Human Normal Immunoglobulin Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Human Normal Immunoglobulin Distributors List Table 186. Human Normal Immunoglobulin Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Human Normal Immunoglobulin Image Figure 2. Global Human Normal Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Normal Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Normal Immunoglobulin Sales (2021-2032) & (K Units) Figure 5. Hepatitis B Immunoglobulins Image Figure 6. Global Hepatitis B Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tetanus Immunoglobulins Image Figure 8. Global Tetanus Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 9. Rabies Immunoglobulins Image Figure 10. Global Rabies Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Human Normal Immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Human Normal Immunoglobulin Market Share by Type 2025 VS 2032 Figure 15. North America Human Normal Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 16. North America Human Normal Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 17. Europe Human Normal Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Human Normal Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Human Normal Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Human Normal Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Human Normal Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Human Normal Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Human Normal Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Human Normal Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Human Normal Immunoglobulin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Government Institutions Image Figure 28. Global Government Institutions Sales YoY Growth (2021-2032) & (K Units) Figure 29. Private Sector Image Figure 30. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Human Normal Immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Normal Immunoglobulin Market Share by Application 2025 VS 2032 Figure 35. North America Human Normal Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Normal Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Normal Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Normal Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Normal Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Normal Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Normal Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Normal Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Normal Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Normal Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 45. North America Human Normal Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Human Normal Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Normal Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Normal Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Normal Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Human Normal Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Normal Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Normal Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Normal Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Human Normal Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Normal Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Normal Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Normal Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Human Normal Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Normal Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Normal Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Normal Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Human Normal Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Normal Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Normal Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Normal Immunoglobulin Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Normal Immunoglobulin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Immunoglobulins
  • Tetanus Immunoglobulins
  • Rabies Immunoglobulins
  • Others
Applications
  • Government Institutions
  • Private Sector
  • Other
Companies covered
  • ADMA Biologics
  • Biotest
  • CBPO
  • CNBG
  • CSL Behring
  • Emergent (Cangene)
  • Grifols
  • Kamada
  • Kedrion
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Normal Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Normal Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Normal Immunoglobulin Market by Type
  6. 1.3.1 Hepatitis B Immunoglobulins
  7. 1.3.2 Tetanus Immunoglobulins
  8. 1.3.3 Rabies Immunoglobulins
  9. 1.3.4 Others
  10. 1.4 Global Human Normal Immunoglobulin Market Size by Type
  11. 1.4.1 Global Human Normal Immunoglobulin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Human Normal Immunoglobulin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Human Normal Immunoglobulin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Human Normal Immunoglobulin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Human Normal Immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Human Normal Immunoglobulin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Human Normal Immunoglobulin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Human Normal Immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Normal Immunoglobulin Industry Trends
  2. 2.2 Human Normal Immunoglobulin Industry Drivers
  3. 2.3 Human Normal Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Human Normal Immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Normal Immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Normal Immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Human Normal Immunoglobulin Price (2021-2026)
  4. 3.4 Global Human Normal Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Normal Immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Human Normal Immunoglobulin Company, Product Type & Application
  7. 3.7 Global Human Normal Immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Normal Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Normal Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Normal Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Human Normal Immunoglobulin Regional Status and Outlook
  1. 4.1 Global Human Normal Immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Normal Immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Human Normal Immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Normal Immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Normal Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Normal Immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Human Normal Immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Normal Immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Normal Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Normal Immunoglobulin by Application
  1. 5.1 Human Normal Immunoglobulin Market by Application
  2. 5.1.1 Government Institutions
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Human Normal Immunoglobulin Market Size by Application
  6. 5.2.1 Global Human Normal Immunoglobulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Normal Immunoglobulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Normal Immunoglobulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Normal Immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Normal Immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Normal Immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Normal Immunoglobulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Normal Immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ADMA Biologics
  2. 6.1.1 ADMA Biologics Company Information
  3. 6.1.2 ADMA Biologics Business Overview
  4. 6.1.3 ADMA Biologics Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ADMA Biologics Human Normal Immunoglobulin Product Portfolio
  6. 6.1.5 ADMA Biologics Recent Developments
  7. 6.2 Biotest
  8. 6.2.1 Biotest Company Information
  9. 6.2.2 Biotest Business Overview
  10. 6.2.3 Biotest Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biotest Human Normal Immunoglobulin Product Portfolio
  12. 6.2.5 Biotest Recent Developments
  13. 6.3 CBPO
  14. 6.3.1 CBPO Company Information
  15. 6.3.2 CBPO Business Overview
  16. 6.3.3 CBPO Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CBPO Human Normal Immunoglobulin Product Portfolio
  18. 6.3.5 CBPO Recent Developments
  19. 6.4 CNBG
  20. 6.4.1 CNBG Company Information
  21. 6.4.2 CNBG Business Overview
  22. 6.4.3 CNBG Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CNBG Human Normal Immunoglobulin Product Portfolio
  24. 6.4.5 CNBG Recent Developments
  25. 6.5 CSL Behring
  26. 6.5.1 CSL Behring Company Information
  27. 6.5.2 CSL Behring Business Overview
  28. 6.5.3 CSL Behring Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Behring Human Normal Immunoglobulin Product Portfolio
  30. 6.5.5 CSL Behring Recent Developments
  31. 6.6 Emergent (Cangene)
  32. 6.6.1 Emergent (Cangene) Company Information
  33. 6.6.2 Emergent (Cangene) Business Overview
  34. 6.6.3 Emergent (Cangene) Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Emergent (Cangene) Human Normal Immunoglobulin Product Portfolio
  36. 6.6.5 Emergent (Cangene) Recent Developments
  37. 6.7 Grifols
  38. 6.7.1 Grifols Company Information
  39. 6.7.2 Grifols Business Overview
  40. 6.7.3 Grifols Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Grifols Human Normal Immunoglobulin Product Portfolio
  42. 6.7.5 Grifols Recent Developments
  43. 6.8 Kamada
  44. 6.8.1 Kamada Company Information
  45. 6.8.2 Kamada Business Overview
  46. 6.8.3 Kamada Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kamada Human Normal Immunoglobulin Product Portfolio
  48. 6.8.5 Kamada Recent Developments
  49. 6.9 Kedrion
  50. 6.9.1 Kedrion Company Information
  51. 6.9.2 Kedrion Business Overview
  52. 6.9.3 Kedrion Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kedrion Human Normal Immunoglobulin Product Portfolio
  54. 6.9.5 Kedrion Recent Developments
  55. 6.10 Hualan Bio
  56. 6.10.1 Hualan Bio Company Information
  57. 6.10.2 Hualan Bio Business Overview
  58. 6.10.3 Hualan Bio Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hualan Bio Human Normal Immunoglobulin Product Portfolio
  60. 6.10.5 Hualan Bio Recent Developments
  61. 6.11 Shanghai RAAS
  62. 6.11.1 Shanghai RAAS Company Information
  63. 6.11.2 Shanghai RAAS Business Overview
  64. 6.11.3 Shanghai RAAS Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai RAAS Human Normal Immunoglobulin Product Portfolio
  66. 6.11.5 Shanghai RAAS Recent Developments
  67. 6.12 Sichuan Yuanda Shuyang
  68. 6.12.1 Sichuan Yuanda Shuyang Company Information
  69. 6.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 6.12.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Portfolio
  72. 6.12.5 Sichuan Yuanda Shuyang Recent Developments
7 North America by Country
  1. 7.1 North America Human Normal Immunoglobulin Sales by Country
  2. 7.1.1 North America Human Normal Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Normal Immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Human Normal Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Normal Immunoglobulin Market Size by Country
  6. 7.2.1 North America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Normal Immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Normal Immunoglobulin Sales by Country
  2. 8.1.1 Europe Human Normal Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Normal Immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Normal Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Normal Immunoglobulin Market Size by Country
  6. 8.2.1 Europe Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Normal Immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Normal Immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Human Normal Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Normal Immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Normal Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Normal Immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Normal Immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Normal Immunoglobulin Sales by Country
  2. 10.1.1 South America Human Normal Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Normal Immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Human Normal Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Normal Immunoglobulin Market Size by Country
  6. 10.2.1 South America Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Normal Immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Normal Immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Human Normal Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Normal Immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Normal Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Normal Immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Human Normal Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Normal Immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Normal Immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Normal Immunoglobulin Value Chain Analysis
  2. 12.1.1 Human Normal Immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Normal Immunoglobulin Production Mode & Process
  7. 12.2 Human Normal Immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Normal Immunoglobulin Distributors
  10. 12.2.3 Human Normal Immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst